Estonia -
Estonian -
Ravimiamet
dolocodon 40 mg toimeainet prolongeeritult vabastav tablett
zentiva k.s. - oksükodoon - toimeainet prolongeeritult vabastav tablett - 40mg 30tk
Estonia -
Estonian -
Ravimiamet
oxycodone kalceks süste-/infusioonilahus
kalceks as - oksükodoon - süste-/infusioonilahus - 10mg 1ml 2ml 10tk; 10mg 1ml 1ml 10tk
Estonia -
Estonian -
Ravimiamet
dolocodon 10 mg toimeainet prolongeeritult vabastav tablett
zentiva k.s. - oksükodoon - toimeainet prolongeeritult vabastav tablett - 10mg 30tk; 10mg 98tk; 10mg 10tk; 10mg 20tk; 10mg 60tk; 10mg 120tk; 10mg 90tk; 10mg 28tk; 10mg 56tk; 10mg 112tk
Estonia -
Estonian -
Ravimiamet
norspan transdermaalne plaaster
mundipharma ges.m.b.h. - buprenorfiin - transdermaalne plaaster - 5mcg 1h 2tk; 5mcg 1h 3tk; 5mcg 1h 8tk; 5mcg 1h 10tk; 5mcg 1h 1tk; 5mcg 1h 4tk; 5mcg 1h 5tk; 5mcg 1h 12tk
Estonia -
Estonian -
Ravimiamet
mezavant gastroresistentne toimeainet prolongeeritult vabastav tablett
shire pharmaceuticals contracts limited - mesalasiin - gastroresistentne toimeainet prolongeeritult vabastav tablett - 1200mg 60tk
Estonia -
Estonian -
Ravimiamet
ventizolve ninasprei, lahus üheannuselises konteineris
dne pharma as - naloksoon - ninasprei, lahus üheannuselises konteineris - 1,26mg 0.1ml 0.1ml 20tk; 1,26mg 0.1ml 0.1ml 2tk
European Union -
Estonian -
EMA (European Medicines Agency)
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastilised ained - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.